Skip to main content

Table 2 Clinical background and staining results of the diseased bladder

From: Expression of parathyroid hormone/parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles: a clinico-pathological study

 

Gender

Age

Maximal Bladder Capacity

Intravesical Pressure at Maximal Capacity (cmH2O)

Compliance (ml/cmH2O)

DO

VUR

Leak Point Pressure (cmH2O)

IHC-PTH1R

Maximal Capacity (ml)

Percent capacity of age standard

Detrusor

Blood vessels

Myelomeningocele-1

M

14

60

17.1

40

1.5

-

-

Incontinent

-

-

Myelomeningocele-2

F

15

117

33.4

53

2.21

-

+

>60

-

+

Myelomeningocele-3

M

20

250

71.4

24

10.4

-

-

25

-

-

Myelomeningocele-4

F

27

147

42.0

30

4.9

-

+

22.5

-

-

Myelomeningocele-5

F

29

212

60.6

23

9.22

+

+

25

-

-

Sacral agenesis-1

M

30

146

41.7

30

4.87

-

+

NA

-

+

Sacral agenesis-2

F

31

266

76.0

30

8.87

-

+

NA

-

-

Posterior urethral valve-1

M

8

109

43.6

47

2.32

-

-

>40

-

+

Posterior urethral valve-2

M

10

147

49.0

40

3.68

-

+

>40

-

+

Posterior urethral valve-3

M

11

5

1.5

107

0.05

+

-

NA

-

-

Hinman syndrome-1

M

8

118

47.2

30

3.93

+

+

>60

-

+

Hinman syndrome-2

M

10

117

39.0

40

2.93

+

-

Incontinent

-

+

Hinman syndrome-3

M

18

303

86.6

10

30.3

+

+

NA

-

+

  1. DO, detrusor overactivity; VUR, vesicouteral reflux; IHC, immunohistochemistry.